Douglas R. Langbehn

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data

Sarah J. Tabrizi, Douglas R. Langbehn, Blair R. Leavitt et al. · The Lancet Neurology · 2009 · 973 citations

Life Sciences, Genetics, Neurology +16

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data

Sarah J. Tabrizi, Rachael I. Scahill, Gail Owen et al. · The Lancet Neurology · 2013 · 839 citations

Life Sciences, Neurology, Neuroscience +15

Detection of Huntington's disease decades before diagnosis: the Predict-HD study

Jane S. Paulsen, Douglas R. Langbehn, Julie C. Stout et al. · Journal of Neurology Neurosurgery & Psychiatry · 2007 · 812 citations · Full text

Life Sciences, Genetics, Neurology +17

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis

Sarah J. Tabrizi, Rachael I. Scahill, Alexandra Dürr et al. · The Lancet Neurology · 2010 · 600 citations

Life Sciences, Neurology, Neuroscience +13

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data

Sarah J. Tabrizi, Ralf Reilmann, Raymund A.C. Roos et al. · The Lancet Neurology · 2011 · 540 citations

Life Sciences, Neurology, Neuroscience +9